Terms: = Breast cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1 AND Prognosis
12 results:
1. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract] [Full Text] [Related]
2. Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer.
Chandran K; Goswami S; Sharma-Walia N
Oncotarget; 2016 Mar; 7(13):15577-99. PubMed ID: 26621841
[TBL] [Abstract] [Full Text] [Related]
3. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human breast cancer Proliferation and BCl2-L1 Expression.
Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
[TBL] [Abstract] [Full Text] [Related]
4. ncoa1 Directly Targets M-CSF1 Expression to Promote breast cancer Metastasis.
Qin L; Wu YL; Toneff MJ; Li D; Liao L; Gao X; Bane FT; Tien JC; Xu Y; Feng Z; Yang Z; Xu Y; Theissen SM; Li Y; Young L; Xu J
Cancer Res; 2014 Jul; 74(13):3477-88. PubMed ID: 24769444
[TBL] [Abstract] [Full Text] [Related]
5. SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer.
Xu Y; Hu B; Qin L; Zhao L; Wang Q; Wang Q; Xu Y; Jiang J
Int J Biol Sci; 2014; 10(4):396-403. PubMed ID: 24719557
[TBL] [Abstract] [Full Text] [Related]
6. Functional and cancer genomics of ASXL family members.
Katoh M
Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract] [Full Text] [Related]
8. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.
Adams BD; Cowee DM; White BA
Mol Endocrinol; 2009 Aug; 23(8):1215-30. PubMed ID: 19423651
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
Green AR; Burney C; Granger CJ; Paish EC; El-Sheikh S; Rakha EA; Powe DG; Macmillan RD; Ellis IO; Stylianou E
Breast Cancer Res Treat; 2008 Aug; 110(3):427-37. PubMed ID: 17902051
[TBL] [Abstract] [Full Text] [Related]
10. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract] [Full Text] [Related]
11. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract] [Full Text] [Related]
12. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract] [Full Text] [Related]
